CPA denounces disinformation on COVID-19
The American College of Physicians (ACP) is speaking out against the spread of disinformation about COVID-19.
In a statement, CPA President George M. Abraham, MD, FACP, FIDSA, discusses concern over disinformation surrounding COVID-19 and the negative impact it is having on public health.
The full statement is below:
The American College of Physicians (ACP), representing 161,000 resident physicians (internists), allied subspecialists and medical students, is concerned about the spread of misinformation about the COVID-19 virus, vaccination and treatments, and its adverse impact on public health. ACP strongly supports the use of science and scientific expertise, based on the best available evidence, in the fight against COVID-19. The spread of inaccurate and incorrect information about COVID-19 is hampering our ability to mitigate the spread of the virus and tackle the global public health crisis.
While ethical and responsible discussions of the evidence and science to inform patient care and scientific and public policy are necessary and appropriate, clinicians, including physicians, should not help disseminate misinformation that can be misinformed. harmful to patients. Physicians have an ethical obligation to put the care and best interests of patients before their personal interests, and to provide patients and the public with accurate health care information. We agree with the US Surgeon General that health misinformation is a serious threat to public health. Contributing to the spread of misinformation that is not factual or based on the best available evidence puts the health of patients, families and communities at risk and thwarts the efforts of all physicians, healthcare workers, researchers and others. people who work tirelessly to fight COVID-19[FEMININE[FEMININE
The CPA calls on doctors, other healthcare professionals and patients to get vaccinated against COVID-19. We also urge continued use of masks as part of a comprehensive public health strategy to help reduce the spread of COVID-19 and slow infection rates.
Physician organizations recently took the offensive in the fight against COVID-19 news as the American Medical Association, American Pharmacists Association and American Society of Health-System Pharmacists spoke out earlier this month – ci to call for the immediate end of prescribing, dispensing and use. ivermectin to prevent or treat COVID-19, other than in clinical trials.
Groups said they were “alarmed” by reports that outpatient prescribing and dispensing of ivermectin has increased 24-fold since the start of the pandemic and “increased exponentially in recent months.”
The groups also say they are urging doctors, pharmacists and other prescribers to warn patients against using ivermectin outside of the FDA-approved indications and advice or buying it from stores in Canada. line, noting that in its veterinary forms, the drug is highly concentrated for use in large animals. and thus poses “a significant risk of toxicity for humans”.
The FDA has approved human use of ivermectin to treat infections caused by internal and external parasites, the statement said, but not to prevent or treat COVID-19. He cites a recent CDC Health Alert Network advisory recommending that healthcare professionals advise patients against using ivermectin as a treatment for COVID-19 and highlight the drug’s “potentially toxic effects”, including nausea, vomiting and diarrhea.
This article was originally published by our sister publication Medical economics.